Extensive visual loss with topical facial steroids.
Steroid creams applied topically to the skin are routinely used in the treatment of many dermatoses. Their use on the face in severe atopic eczema is relatively common. We report a series of three patients who whilst using topical facial steroids developed advanced glaucoma. A further two cases of ocular hypertension secondary to topical facial steroids are also described. This is the first series of cases to be reported demonstrating the potentially blinding complications of topical facial steroids. Recommendations are made with regard to screening such patients for glaucoma.
Aggarwal
R K
RK
Birmingham and Midland Eye Hospital, UK.
Potamitis
T
T
Chong
N H
NH
Guarro
M
M
Shah
P
P
Kheterpal
S
S
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D002990:Clobetasol / Q000009:adverse effects / Q000031:analogs & derivatives*; D003876:Dermatitis, Atopic / Q000188:drug therapy; D003899:Desoximetasone / Q000009:adverse effects*; D005148:Facial Dermatoses / Q000188:drug therapy*; D005260:Female; D005901:Glaucoma / Q000139:chemically induced*; D006801:Humans; D006854:Hydrocortisone; D008297:Male; D009798:Ocular Hypertension / Q000139:chemically induced*; D011239:Prednisolone; D014786:Vision Disorders / Q000139:chemically induced*; D014792:Visual Acuity
D000893:Anti-Inflammatory Agents; D003899:Desoximetasone; C010893:clobetasone butyrate; D011239:Prednisolone; D002990:Clobetasol; D006854:Hydrocortisone